Shigella are versatile mucosal pathogens that circumvent the host innate immune system

Current Opinion in Immunology

Volumn 23, Issue 4, 2011, Pages 448-455

  Ashida, Hiroshi ^a   Ogawa, Michinaga ^a   Mimuro, Hitomi ^a   Kobayashi, Taira ^a   Sanada, Takahito ^a   Sasakawa, Chihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN RECOGNITION; AUTOPHAGY; CELL DEATH; CELL INVASION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE MUCOSA; MACROPHAGE; MUCOSA INFLAMMATION; NEUTROPHIL; NONHUMAN; PROTEIN SECRETION; REVIEW; SHIGELLOSIS; SIGNAL TRANSDUCTION; TH17 CELL;

ACTINS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; AUTOPHAGY; CYTOPLASM; DYSENTERY, BACILLARY; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTESTINAL MUCOSA; MACROPHAGES; MODELS, BIOLOGICAL; NECROSIS; NEUTROPHILS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEPTINS; SHIGELLA; TH17 CELLS;

EID: 80052361387     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.06.001     Document Type: Review

References (54)

1. Phalipon A., Sansonetti P.J. Shigella's way of manipulating host intestinal innate and adaptive immune system: a tool box for survival?. Immunol Cell Biol 2007, 85:119-129.
2. Ogawa M., Handa Y., Ashida H., Suzuki M., Sasakawa C. The versatility of Shigella effectors. Nat Rev Microbiol 2008, 6:11-16.
3. Ashida H., Ogawa M., Mimuro H., Sasakawa C. Shigella infection of intestinal epithelium and circumvention of the host innate defense system. Curr Top Microbiol Immunol 2009, 337:231-255.
4. Ashida H., Ogawa M., Kim M., Suzuki S., Sanada T., Punginelli C., Mimuro H., Sasakawa C. Shigella deploy multiple countermeasures against host innate immune responses. Curr Opin Microbiol 2011, 14:16-23.
5. Bergsbaken T., Fink S.L., Cookson B.T. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009, 7:99-109.
6. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
7. Suzuki T., Franchi L., Toma C., Ashida H., Ogawa M., Yoshikawa Y., Mimuro H., Inohara N., Sasakawa C., Nuñez G. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog 2007, 3:e111.
8. Miao E.A., Mao D.P., Yudkovsky N., Bonneau R., Lorang C.G., Warren S.E., Leaf I.A., Aderem A. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A 2010, 107:3076-3080.
9. Willingham S.B., Bergstralh D.T., O'Connor W., Morrison A.C., Taxman D.J., Duncan J.A., Barnoy S., Venkatesan M.M., Flavell R.A., Deshmukh M., et al. Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe 2007, 2:147-159.
10. Suzuki T., Yoshikawa Y., Ashida H., Iwai H., Toyotome T., Matsui H., Sasakawa C. High vaccine efficacy against shigellosis of recombinant noninvasive Shigella mutant that expresses Yersinia invasin. J Immunol 2006, 177:4709-4717.
11. Franchi L., Warner N., Viani K., Nuñez G. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009, 227:106-128.
12. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
13. Ting J.P., Duncan J.A., Lei Y. How the noninflammasome NLRs function in the innate immune system. Science 2010, 327:286-290.
14. Takahashi I., Nochi T., Yuki Y., Kiyono H. New horizon of mucosal immunity and vaccines. Curr Opin Immunol 2009, 21:352-358.
15. Levine M.M., Kotloff K.L., Barry E.M., Pasetti M.F., Sztein M.B. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 2007, 5:540-553.
16. Boullier S., Tanguy M., Kadaoui K.A., Caubet C., Sansonetti P., Corthésy B., Phalipon A. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits. J Immunol 2009, 183:5879-5885.
17. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003, 3:710-720.
18. Lai Y., Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 2009, 30:131-141.
19. Fernandez M.I., Thuizat A., Pedron T., Neutra M., Phalipon A., Sansonetti P.J. A newborn mouse model for the study of intestinal pathogenesis of shigellosis. Cell Microbiol 2003, 5:481-491.
20. Fernandez M.I., Regnault B., Mulet C., Tanguy M., Jay P., Sansonetti P.J., Pédron T. Maturation of paneth cells induces the refractory state of newborn mice to Shigella infection. J Immunol 2008, 180:4924-4930.
21. Raqib R., Sarker P., Bergman P., Ara G., Lindh M., Sack D.A., Nasirul Islam K.M., Gudmundsson G.H., Andersson J., Agerberth B. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A 2006, 103:9178-9183.
22. Shim D.H., Ryu S., Kweon M.N. Defensins play a crucial role in protecting mice against oral Shigella flexneri infection. Biochem Biophys Res Commun 2010, 401:554-560.
23. Perdomo J.J., Gounon P., Sansonetti P.J. Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. J Clin Invest 1994, 93:633-643.
24. Perdomo O.J., Cavaillon J.M., Huerre M., Ohayon H., Gounon P., Sansonetti P.J. Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med 1994, 180:1307-1319.
25. Weinrauch Y., Drujan D., Shapiro S.D., Weiss J., Zychlinsky A. Neutrophil elastase targets virulence factors of enterobacteria. Nature 2002, 417:91-94.
26. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
27. Papayannopoulos V., Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol 2009, 30:513-521.
28. Le-Barillec K., Magalhaes J.G., Corcuff E., Thuizat A., Sansonetti P.J., Phalipon A., Di Santo J.P. Roles for T and NK cells in the innate immune response to Shigella flexneri. J Immunol 2005, 175:1735-1740.
29. Sellge G., Magalhaes J.G., Konradt C., Fritz J.H., Salgado-Pabon W., Eberl G., Bandeira A., Di Santo J.P., Sansonetti P.J., Phalipon A. Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. J Immunol 2010, 184:2076-2085.
30. Curtis M.M., Way S.S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 2009, 126:177-185.
31. Kufer T.A., Kremmer E., Adam A.C., Philpott D.J., Sansonetti P.J. The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction. Cell Microbiol 2007, 10:477-486.
32. Kasper C.A., Sorg I., Schmutz C., Tschon T., Wischnewski H., Kim M.L., Arrieumerlou C. Cell-cell propagation of NF-κB transcription factor and MAP kinase activation amplifies innate immunity against bacterial infection. Immunity 2010, 33:804-816.
33. Dolowschiak T., Chassin C., Ben Mkaddem S., Fuchs T.M., Weiss S., Vandewalle A., Hornef M.W. Potentiation of epithelial innate host responses by intercellular communication. PLoS Pathog 2010, 6:e1001194.
34. Deretic V. Autophagy in infection. Curr Opin Cell Biol 2010, 22:252-262.
35. Chen G.Y., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010, 10:826-837.
36. Travassos L.H., Carneiro L.A., Ramjeet M., Hussey S., Kim Y.G., Magalhães J.G., Yuan L., Soares F., Chea E., Le Bourhis L., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010, 11:55-62.
37. Ogawa M., Yoshimori T., Suzuki T., Sagara H., Mizushima N., Sasakawa C. Escape of intracellular Shigella from autophagy. Science 2005, 307:727-731.
38. Mostowy S., Bonazzi M., Hamon M.A., Tham T.N., Mallet A., Lelek M., Gouin E., Demangel C., Brosch R., Zimmer C., et al. Entrapment of intracytosolic bacteria by septin cage-like structures. Cell Host Microbe 2010, 8:433-444.
39. Mostowy S., Nam Tham T., Danckaert A., Guadagnini S., Boisson-Dupuis S., Pizarro-Cerdá J., Cossart P. Septins regulate bacterial entry into host cells. PLoS ONE 2009, 4:e4196.
40. Marteyn B., West N.P., Browning D.F., Cole J.A., Shaw J.G., Palm F., Mounier J., Prévost M.C., Sansonetti P., Tang C.M. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 2010, 465:355-358.
41. West N.P., Sansonetti P., Mounier J., Exley R.M., Parsot C., Guadagnini S., Prévost M.C., Prochnicka-Chalufour A., Delepierre M., Tanguy M., et al. Optimization of virulence functions through glucosylation of Shigella LPS. Science 2005, 307:1313-1317.
42. Parsot C. Shigella type III secretion effectors: how, where, when, for what purposes?. Curr Opin Microbiol 2009, 12:110-116.
43. Arbibe L., Kim D.W., Batsche E., Pedron T., Mateescu B., Muchardt C., Parsot C., Sansonetti P.J. An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription of host genes involved in immune responses. Nat Immunol 2007, 8:47-56.
44. Li H., Xu H., Zhou Y., Zhang J., Long C., Li S., Chen S., Zhou J.M., Shao F. The phosphothreonine lyase activity of a bacterial type III effector family. Science 2007, 315:1000-1003.
45. Collins C.A., Brown E.J. Cytosol as battleground: ubiquitin as a weapon for both host and pathogen. Trends Cell Biol 2010, 20:205-213.
46. Kim D.W., Lenzen G., Page A.L., Legrain P., Sansonetti P.J., Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A 2005, 102:14046-14051.
47. Newton H.J., Pearson J.S., Badea L., Kelly M., Lucas M., Holloway G., Wagstaff K.M., Dunstone M.A., Sloan J., Whisstock J.C., et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-κB p65. PLoS Pathog 2010, 6:e1000898.
48. Ashida H., Toyotome T., Nagai T., Sasakawa C. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors. Mol Microbiol 2007, 63:680-693.
49. Rohde J.R., Breitkreutz A., Chenal A., Sansonetti P.J., Parsot C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligase. Cell Host Microbe 2007, 1:77-83.
50. Singer A.U., Rohde J.R., Lam R., Skarina T., Kagan O., DiLeo R., Chirgadze N.Y., Cuff M.E., Joachimiak A., Tyers M., et al. Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases. Nat Struct Mol Biol 2008, 15:1293-1301.
51. Zhu Y., Li H., Hu L., Wang J., Zhou Y., Pang Z., Liu L., Shao F. Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat Struct Mol Biol 2008, 15:1302-1308.
52. Ashida H., Kim M., Schmidt-Supprian M., Ma A., Ogawa M., Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKγ to dampen the host NF-κB-mediated inflammatory response. Nat Cell Biol 2010, 12:66-73.
53. Okukda J., Toyotome T., Kataoka N., Ohno M., Abe H., Shimura Y., Seyedarabi A., Pichersgill R., Sasakawa C. Shigella effector IpaH9.8 binds to a splicing factor U2AF35 to modulate host immuno responses. Biochem Biophys Res Commun 2005, 333:531-539.
54. Seyedarabi A., Sullivan J.A., Sasakawa C., Pickersgill R.W. A disulfide driven domain swap switches off the activity of Shigella IpaH9.8 E3 ligase. FEBS Lett 2010, 584:4163-4168.